NCT00914290View on ClinicalTrials.gov

A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis

PHASE2CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

January 31, 2010

Study Completion Date

February 28, 2010

Conditions
SpasticityMultiple Sclerosis
Interventions
DRUG

IPX056

IPX056 ER capsule containing 10 mg baclofen

DRUG

Baclofen IR

Encapsulated baclofen tablet 5 mg per capsule

DRUG

Placebo IPX056

Placebo capsule for IPX056

DRUG

Placebo IR

Placebo encapsulated baclofen placebo tablet

Trial Locations (11)

11501

Winthrop University Hospital, Mineola

12110

Empire Neurology, PC, Latham

27157

Wake Forest University Health Sciences, Winston-Salem

33606

Meridien Research, Tampa

46805

Fort Wayne Neurological Center, Fort Wayne

48025

QUEST Research Institute, Bingham Farms

59405

Great Falls Cllinic, Great Falls

66214

MidAmerica Neuroscience Institute, Lenexa

78681

Central Texas Neurology Consultants, Round Rock

80045

University of Colorado, Aurora

85741

Northwest NeuroSpecialists, PLLC, Tucson

Sponsors
All Listed Sponsors
lead

Impax Laboratories, LLC

INDUSTRY

NCT00914290 - A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis | Biotech Hunter | Biotech Hunter